遠隔性不血性予備条件の血小板活性化と,心房細動のためのアブレーションによって誘発された反応性に対する影響

Alessandra Stazi1, Giancarla Scalone, Marianna Laurito

  • 1Institute of Cardiology, Università Cattolica del Sacro Cuore, Rome, Italy.

Circulation
|November 27, 2013
PubMed
まとめ

動脈細動の消去前にリモート・イシュケミック・プリコンディショニング (IPC) が行程によって誘発される血小板活性化を低下させる. この発見は,IPCが,放射性アブレーションに関連する血栓栓塞栓リスクを軽減することを示唆しています.

関連する概念動画

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K